Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-03

FDA Approved: CARVEDILOL — Supplemental Application (Quallent Pharmaceuticals Health LLC)

View source ↗

Summary

FDA approves a supplemental application for carvedilol from Quallent Pharmaceuticals Health LLC, approving an updated generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARVEDILOL (Carvedilol)

Snippet

SUPPL AP for CARVEDILOL (CARVEDILOL)